MSB 7.69% $1.19 mesoblast limited

banter and General Discussion, page-10130

  1. 11,103 Posts.
    lightbulb Created with Sketch. 696
    One could be forgiven for thinking the FDA needed an embarrassed push from lagging published research findings rather than a pull from leading research years before the research papers get published........

    Catching up rather than regulating leading research....

    Or slowing down competitors to Big Pharma.

    Take your pick as to best pick.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.